CHMP2A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.419180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.549370E-01
Normal-vs-Stage2
1.542040E-01
Normal-vs-Stage3
3.818400E-01
Normal-vs-Stage4
2.163400E-01
Stage1-vs-Stage2
8.240800E-01
Stage1-vs-Stage3
7.119000E-01
Stage1-vs-Stage4
5.850000E-01
Stage2-vs-Stage3
7.068200E-01
Stage2-vs-Stage4
6.709800E-01
Stage3-vs-Stage4
9.838400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.553430E-01
Normal-vs-AfricanAmerican
1.761010E-01
Normal-vs-Asian
1.203990E-01
Caucasian-vs-AfricanAmerican
7.655800E-01
Caucasian-vs-Asian
1.367570E-01
AfricanAmerican-vs-Asian
3.687200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.331840E-01
Normal-vs-Female
1.576580E-01
Male-vs-Female
8.057900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.892800E-01
Normal-vs-Age(41-60Yrs)
1.047970E-01
Normal-vs-Age(61-80Yrs)
1.812410E-01
Normal-vs-Age(81-100Yrs)
5.121700E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.377000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.184400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.920610E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.155000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.687200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.156800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.088000E-01
Normal-vs-Daily Drinker
1.419620E-01
Normal-vs-Weekly Drinker
1.457180E-01
Normal-vs-Occasional Drinker
7.547800E-02
Normal-vs-Social Drinker
1.921610E-01
Non Drinker-vs-Daily Drinker
4.884200E-02
Non Drinker-vs-Weekly Drinker
2.694000E-01
Non Drinker-vs-Occasional Drinker
2.759700E-02
Non Drinker-vs-Social Drinker
8.461400E-01
Daily Drinker-vs-Weekly Drinker
3.998400E-01
Daily Drinker-vs-Occasional Drinker
9.419200E-01
Daily Drinker-vs-Social Drinker
7.439900E-02
Weekly Drinker-vs-Occasional Drinker
3.708200E-01
Weekly Drinker-vs-Social Drinker
3.703800E-01
Occasional Drinker-vs-Social Drinker
6.914100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.732200E-02
Normal-vs-Grade 2
6.103900E-03
Normal-vs-Grade 3
2.250400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.852000E-01
Grade 1-vs-Grade 3
8.674200E-01
Grade 1-vs-Grade 4
6.732200E-02
Grade 2-vs-Grade 3
7.686600E-01
Grade 2-vs-Grade 4
6.103900E-03
Grade 3-vs-Grade 4
2.250400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.008000E-01
Normal-vs-NonDiabetic
7.500100E-02
Diabetic-vs-NonDiabetic
1.797560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.619600E-02
Normal-vs-NoPancreatitis
1.460630E-01
Pancreatitis-vs-NoPancreatitis
4.889600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.544100E-02
Normal-vs-N1
1.793450E-01
N0-vs-N1
9.227900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.170300E-02
Normal-vs-TP53-NonMutant
5.380400E-01
TP53-Mutant-vs-TP53-NonMutant
1.96610999999569E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
